Financial statements Biopangea
Balance sheet data of BIOPANGEA
|
Year
|
2020
|
2021
|
2022
|
|---|---|---|---|
| Total assets | 180 339,39 | 683 841,74 | 623 815,94 |
| A. Fixed assets | 0,00 | 128 483,38 | 150 725,85 |
| B. Current assets | 180 339,39 | 555 358,36 | 473 090,09 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 |
| Total liabilities | 180 339,39 | 683 841,74 | 623 815,94 |
| A. Equity | -288 620,47 | 20 745,48 | 471 234,12 |
| B. Liabilities and provisions for liabilities | 468 959,86 | 663 096,26 | 152 581,82 |
| I. Long-term liabilities | - | - | - |
| II. Short-term liabilities | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.